Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study.

Katsuya YamaguchiTakashi KawaharaAkihito HashizumeKimito OusakaKoichi UemuraYusuke ItoHiroki ItoKazuhide MakiyamaHiroji Uemura

Published in: Diseases (Basel, Switzerland) (2024)

ENZ was shown to prolong OS relative to cabazitaxel after the cessation of docetaxel. ENZ was associated with a longer duration of drug use than ABI and CBZ.

Keyphrases

prostate cancer
locally advanced
squamous cell carcinoma
emergency department
radiation therapy
rectal cancer